AU6456096A - Lysine 1689 factor viii:c polypeptide analogs - Google Patents

Lysine 1689 factor viii:c polypeptide analogs

Info

Publication number
AU6456096A
AU6456096A AU64560/96A AU6456096A AU6456096A AU 6456096 A AU6456096 A AU 6456096A AU 64560/96 A AU64560/96 A AU 64560/96A AU 6456096 A AU6456096 A AU 6456096A AU 6456096 A AU6456096 A AU 6456096A
Authority
AU
Australia
Prior art keywords
lysine
factor viii
polypeptide analogs
analogs
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64560/96A
Inventor
Rae Lyn Burke
Steven Rosenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of AU6456096A publication Critical patent/AU6456096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU64560/96A 1995-07-11 1996-07-09 Lysine 1689 factor viii:c polypeptide analogs Abandoned AU6456096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US102995P 1995-07-11 1995-07-11
US001029 1995-07-11
PCT/US1996/011441 WO1997003194A1 (en) 1995-07-11 1996-07-09 Lysine 1689 factor viii:c polypeptide analogs

Publications (1)

Publication Number Publication Date
AU6456096A true AU6456096A (en) 1997-02-10

Family

ID=21694040

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64560/96A Abandoned AU6456096A (en) 1995-07-11 1996-07-09 Lysine 1689 factor viii:c polypeptide analogs

Country Status (2)

Country Link
AU (1) AU6456096A (en)
WO (1) WO1997003194A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3202797A (en) 1996-04-24 1997-11-12 Regents Of The University Of Michigan, The Inactivation resistant factor viii
US8183344B2 (en) 1996-04-24 2012-05-22 University Of Michigan Inactivation resistant factor VIII
EP1980617A1 (en) 1998-12-31 2008-10-15 Novartis Vaccines and Diagnostics, Inc. Improved expression of HIV polypeptides and production of virus-like particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451521A (en) * 1986-05-29 1995-09-19 Genetics Institute, Inc. Procoagulant proteins
DE3720246A1 (en) * 1987-06-19 1988-12-29 Behringwerke Ag FACTOR VIII: C-LIKE MOLECULE WITH COAGULATION ACTIVITY

Also Published As

Publication number Publication date
WO1997003194A1 (en) 1997-01-30

Similar Documents

Publication Publication Date Title
AU7203496A (en) Novel peptides
AU5801296A (en) Crosslinkable polypeptide compositions
AU4715493A (en) Peptide compounds
AU6486196A (en) Novel factor viii:c polypeptide analogs with altered protease sites
AU6360394A (en) Vasonatrin peptide and analogs thereof
AU629097B2 (en) Nail sustainer
AU1398792A (en) Hybrid polypeptide
AU6455896A (en) Novel factor viii:c polypeptide analogs with altered metal-binding properties
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU4251193A (en) Retinoblastoma-associated protein 1 cDNA
AU3977589A (en) Novel peptides
AU4628993A (en) Physiologically active peptide composition
AU4271793A (en) Novel polypeptide
EP0811014A4 (en) Novel bacteriocin piscicolin 126
AU3103595A (en) Novel compound to mimic a naturally occurring peptide's effect
AU4012795A (en) Alzheimer's peptide
AU6456096A (en) Lysine 1689 factor viii:c polypeptide analogs
AU6291896A (en) Novel factor viii:c polypeptide analogs comprising factor v domains or subdomains
AU5483596A (en) Neuropeptide y analogs
AU4453396A (en) Growth factor analogs
GB9506372D0 (en) New peptide compounds
AU3734693A (en) Neurotrophic peptides
AU5161296A (en) Anti-haemorrhagic peptides
AU1346092A (en) Angiogenic peptides